ABSTRACT
BACKGROUND: The leaves of Origanum majorana (O. majorana) are traditionally renowned for treating diarrhea and gut spasms. This study was therefore planned to evaluate its methanolic extract. METHODS: Gas chromatography-mass spectrometry (GC-MS) was used to identify the phytochemicals, and Swiss albino mice were used for an in vivo antidiarrheal assay. Isolated rat ileum was used as an ex vivo assay model to study the possible antispasmodic effect and its mechanism(s). RESULTS: The GC-MS analysis of O. majorana detected the presence of 21 compounds, of which alpha-terpineol was a major constituent. In the antidiarrheal experiment, O. majorana showed a substantial inhibitory effect on diarrheal episodes in mice at an oral dosage of 200 mg/kg, resulting in 40% protection. Furthermore, an oral dosage of 400 mg/kg provided even greater protection, with 80% effectiveness. Similarly, loperamide showed 100% protection at oral doses of 10 mg/kg. O. majorana caused complete inhibition of carbachol (CCh, 1 µM) and high K+ (80 mM)-evoked spasms in isolated ileal tissues by expressing significantly higher potency (p < 0.05) against high K+ compared to CCh, similar to verapamil, a Ca++ antagonist. The verapamil-like predominant Ca++ ion inhibitory action of O. majorana was further confirmed in the ileal tissues that were made Ca++-free by incubating the tissues in a physiological salt solution having ethylenediaminetetraacetic acid (EDTA) as a chelating agent. The preincubation of O. majorana at increasing concentrations (0.3 and 1 mg/mL) shifted towards the right of the CaCl2-mediated concentration-response curves (CRCs) with suppression of the maximum contraction. Similarly, verapamil also caused non-specific suppression of Ca++ CRCs towards the right, as expected. CONCLUSIONS: Thus, this study conducted an analysis to determine the chemical constituents of the leaf extract of O. majorana and provided a detailed mechanistic basis for the medicinal use of O. majorana in hyperactive gut motility disorders.
Subject(s)
Antidiarrheals , Origanum , Rats , Mice , Animals , Antidiarrheals/pharmacology , Antidiarrheals/therapeutic use , Antidiarrheals/chemistry , Jejunum , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Plant Extracts/chemistry , Castor Oil/pharmacology , Castor Oil/therapeutic use , Diarrhea/drug therapy , Verapamil/pharmacology , Verapamil/therapeutic use , Calcium Channels , Spasm/drug therapyABSTRACT
OBJECTIVES: Nigeria ranks second in the global prevalence of diarrhoea with most cases concentrated in the Northern-region of the country. This research explored the antidiarrhoeal efficacy of the hydroethanolic extract of Piliostigma thonningii leaves (HEPTL), locally used to manage diarrhoeal conditions in Kebbi State, Nigeria. METHODS: P. thonningii leaves were screened for their secondary metabolites and mineral constituents. Using 3 standard-diarrhoea models, female Wistar rats completely-randomised into six-groups of six animals each were utilised for probing the antidiarrhoeal activity of HEPTL. Animals in groups I and II served as the negative and positive controls, whereas the rats in groups III, IV and V respectively received 50, 100, and 200â¯mg/kg body weight-(bw) of HEPTL. RESULTS: Six secondary metabolites and eight minerals were found in the extract, with flavonoids and calcium being the most abundant while steroids and zinc were the least prevalent, respectively. High performance liquid chromatographic analysis revealed the presence of 19 bioactive substances. Furthermore, there was a significant (p<0.05) and dose-related reduction in diarrhoea onset, water content, and wet faeces count. Similarly, the amount of intestinal fluid and average distance traversed by the charcoal-meal were decreased dose-dependently by the HEPTL with a commensurate rise in the suppression of intestinal fluid accrual and peristalsis. Acetylcholinesterase, Na+/K+-ATPase, reduced glutathione, intestinal-alkaline phosphatase and protein levels increased significantly (p<0.05) whereas superoxide-dismutase, catalase, intestinal-nitric oxide and malondialdehyde levels all fell significantly (p<0.05). However, the level of intestinal glucose was not significantly altered. CONCLUSIONS: Overall, the HEPTL exhibited a profound effect in the alleviation of the severity of diarrhoea, notably at 200â¯mg/kg bw.
Subject(s)
Antidiarrheals , Fabaceae , Rats , Female , Animals , Rats, Wistar , Antidiarrheals/pharmacology , Antidiarrheals/therapeutic use , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Plant Extracts/analysis , Phytotherapy , Acetylcholinesterase , Castor Oil/analysis , Castor Oil/therapeutic use , Diarrhea/drug therapy , Fabaceae/chemistry , Plant Leaves/chemistryABSTRACT
INTRODUCTION: Infraorbital hyperpigmentation represents one of the most prevalent conditions in cosmetic dermatology. To treat this condition, many patients prefer natural remedies. This study explored the efficacy of topical castor oil cream in treating patients with infraorbital hyperpigmentation. METHODS: We conducted an exploratory single-arm clinical trial at the Shahid Faghihi Dermatology Clinic and Molecular Dermatology Research Center of Shiraz University of Medical Sciences, Shiraz, Iran, during 2021-2022. Using the convenience sampling method, we enrolled 25 patients with infraorbital hyperpigmentation. We instructed the patients to apply topical castor oil cream twice daily for 2 months. The darkness, melanin, and erythema levels were evaluated by VisioFace® 1000 D and SkinColorCatch® devices. We used a visual analog scale to assess skin laxity, wrinkles, and patient satisfaction. Data analysis was done with Stata version 14.2. RESULTS: The data of 22 patients with a mean age of 40.92 ± 7.33 years were analyzed. The VisioFace® scores decreased significantly by the end of the study [right eyes: mean difference (MD): -5.63 (95% CI: -7.12 to -4.15), p < 0.001; left eyes: MD: -5.91 (95% CI: -7.46 to -4.36), p < 0.001]. Moreover, castor oil cream significantly reduced the melanin level, wrinkles, and skin laxity in the infraorbital region (p < 0.05). CONCLUSIONS: Castor oil cream seems to be an effective alternative for treating infraorbital hyperpigmentation. Randomized clinical trials are needed to confirm our findings.
Subject(s)
Castor Oil , Hyperpigmentation , Adult , Humans , Middle Aged , Castor Oil/therapeutic use , Cosmetics/therapeutic use , Emollients/therapeutic use , Hyperpigmentation/drug therapy , Melanins , Skin Cream , Treatment OutcomeABSTRACT
In dogs, Rhipicephalus linnaei transmits pathogens such as Ehrlichia canis, Babesia vogeli, and Hepatozoon canis. The veterinary market has synthetic acaricides to ticks control. Esters derived from castor oil are efficient. However, there is little information about their effects on non-target organisms. This work consisted of a clinical (AST, ALT, and ALP) and histological and histochemical analysis (liver and spleen) of female rabbits exposed to these esters and afoxolaner. The rabbits were divided into three groups: control group (CG) received Bandeirante® rabbit feed; the afoxolaner treatment (TG1) received rabbit feed and two doses of afoxolaner; castor oil esters treatment (TG2) received rabbit feed enriched with esters (1.75 g esters/kg). No alterations were observed in the AST, ALT, and ALP enzymes in exposure to esters TG2. Rabbits from TG1 showed changes in AST. The liver of rabbits exposed to afoxolaner underwent histological and histochemical changes, such as steatosis and vacuolation, as well as poor protein labeling. Polysaccharides were intensely observed in the group exposed to esters. The spleen showed no changes in any of the exposure. Esters from castor oil caused fewer liver changes when incorporated into the feed and fed to rabbits than exposure to afoxolaner.
Subject(s)
Acaricides , Dog Diseases , Rhipicephalus sanguineus , Rhipicephalus , Female , Rabbits , Animals , Dogs , Castor Oil/chemistry , Castor Oil/pharmacology , Castor Oil/therapeutic use , Acaricides/pharmacology , Spleen , Esters/pharmacology , Esters/therapeutic use , Liver , Dog Diseases/parasitologyABSTRACT
The multifactorial pathogenesis and interrelationship of blepharitis, meibomian gland dysfunction and dry eye disease poses challenges to any therapeutic approach. Current treatments are mostly palliative, with success limited by perceived inefficacy and poor patient compliance. Castor oil, a natural derivative of the Ricinus communis plant, is widely used as an emollient in cosmetics and personal care products, drug delivery systems and wound dressings. Castor oil is deemed safe and tolerable, with strong anti-microbial, anti-inflammatory, anti-nociceptive, analgesic, antioxidant, wound healing and vaso-constrictive properties. Its main constituent, ricinoleic acid, has a bipolar molecular structure that promotes the formation of esters, amides and polymers. These can supplement deficient physiological tear film lipids, enabling enhanced lipid spreading characteristics and reducing aqueous tear evaporation. Studies reveal that castor oil applied topically to the ocular surface has a prolonged residence time, facilitating increased tear film lipid layer thickness, stability, improved ocular surface staining and symptoms. This review summarises the properties, current uses of, and therapeutic potential of castor oil in managing ocular surface disease. The biochemical, medicinal actions of castor oil are explored from the perspective of ocular surface pathology, and include microbial and demodectic over-colonisation, inflammatory and oxidative processes, as well as clinical signs and symptoms of dryness and discomfort.
Subject(s)
Blepharitis , Castor Oil , Dry Eye Syndromes , Meibomian Gland Dysfunction , Blepharitis/drug therapy , Castor Oil/therapeutic use , Dry Eye Syndromes/drug therapy , Humans , Meibomian Glands , TearsABSTRACT
OBJECTIVE: The main purpose of this study was to evaluate the characteristics of a vegetal polymeric biomaterial intended for bone substitution in horses and to investigate the responses of the equine third metacarpal bone to biomaterial implantation. MATERIALS AND METHODS: Six horses were submitted to osteotomy on the dorsal aspect of the left and right third metacarpal bones; one bone defect was randomly selected for treatment with biopolymer, while the other was left untreated and served as a control. Bone density was monitored radiographically after surgery and bone biopsy fragments were collected at the end of the 120-day follow-up period. Biopsy fragments were analysed using light and scanning electron microscopy. RESULTS: Mean bone density values (mmAL) were greater in control defects (16.33 ± 1.6) than in polymer-treated defects (14.17 ± 1.7) at 120 days (p = 0.027). Light microscopy revealed greater percentages of new bone formation in control defects (50.15 ± 14.8) than in polymer treated defects (26.94 ± 12.1) at 120 days (p < 0.0001). Scanning electron microscopy analysis suggested a similar quality of pre-existing bone and new bone formed in the presence of biomaterial. CLINICAL SIGNIFICANCE: The absence of adverse reactions supports biomaterial biocompatibility and osteoconducting capacity and suggests the castor oil polymer is a suitable bone substitute for the treatment of bone defects in horses.
Subject(s)
Bone Substitutes/therapeutic use , Castor Oil/therapeutic use , Metacarpal Bones/surgery , Animals , Biocompatible Materials/therapeutic use , Bone Density , Bone Regeneration/drug effects , Horses/surgery , Male , Metacarpal Bones/diagnostic imaging , Metacarpal Bones/ultrastructure , Microscopy, Electron, Scanning/veterinary , Osteotomy/veterinary , Polymers/therapeutic use , RadiographyABSTRACT
PURPOSE: The aim of this study is to investigate the safety and efficacy of castor oil to induce labour. MATERIALS AND METHODS: A retrospective observational case control study was conducted over five years. Castor oil was proposed to women referred to the Birth Centre (Castor Oil group (COG)). They were compared to women who chose to be followed by the traditional doctor-led unit (control group (CG)). Castor oil was administered in a 60 ml single dose in 200 ml of warm water. Inclusion criteria were gestational age between 40 and 41 weeks plus premature rupture of membranes between 12 and 18 hours or amniotic fluid index ≤4 or Bishop Score of ≤4 or absence of spontaneous labour over 41 + 4 weeks. RESULTS: Pharmacological induction of labour was required for 18 women in the COG (45%) and 36 in the CG (90%) (p < .001). The mode of delivery differed significantly between groups: women assuming castor oil showed a higher incidence of vaginal delivery, whereas the incidence of caesarean section was lower in the COG, but no statistical significance was reached. CONCLUSIONS: The use of castor oil is related to a higher probability of labour initiation within 24 hours. Castor oil can be considered a safe non-pharmacological method for labour induction.
Subject(s)
Castor Oil/therapeutic use , Labor, Induced/methods , Oxytocics/therapeutic use , Adult , Case-Control Studies , Cervical Ripening/drug effects , Cesarean Section/statistics & numerical data , Female , Humans , Labor, Induced/adverse effects , Labor, Induced/statistics & numerical data , Misoprostol/therapeutic use , Pregnancy , Pregnancy Outcome/epidemiology , Retrospective Studies , Treatment Outcome , Young AdultABSTRACT
Ricinus cmmunis L. (Castor oil plant) is an important medicinal plant belonging to family Euphorbiaceae. Its phytochemistry, biological and pharmacological activities, and ethnomedicinal uses have been reviewed in the present study. The reported chemical constituents showed the presence of flavonoids, phenolic compounds, fatty acids, amino acids, terpenoids, phytosterol etc. The compounds have been reported to exhibit anticonceptive, antidiabetic, antifertility, anti-inflammatory, antimicrobial, antioxidant, hepatoprotective, insecticidal and wound-healing activities. They also showed free radical scavenging and Hg scavenging activities, and repellent properties. Various parts of R. communis have been widely used in traditional medicine such as abdominal disorders, arthritis, backache, muscle aches, bilharziasis, chronic backache and sciatica, chronic headache, constipation, expulsion of placenta, gallbladder pain, period pain, menstrual cramps, rheumatism, sleeplessness, and insomnia. Castor oil plant has also revealed toxic effects due to the presence of ricin (protein) and ricinine (alkaloid). Comparatively, ricin is more toxic. But still there is need of more research to be conducted with reference to its medicinal importance (particularly exploring of medicinal recipes) and active compounds responsible for various activities.
Subject(s)
Castor Oil/therapeutic use , Medicine, Traditional , Plant Extracts/therapeutic use , Ricinus , Alkaloids/adverse effects , Alkaloids/isolation & purification , Animals , Castor Oil/adverse effects , Castor Oil/isolation & purification , Humans , Patient Safety , Plant Extracts/adverse effects , Plant Extracts/isolation & purification , Pyridones/adverse effects , Pyridones/isolation & purification , Ricin/adverse effects , Ricin/isolation & purification , Ricinus/adverse effects , Ricinus/chemistry , Risk AssessmentABSTRACT
STATEMENT OF PROBLEM: The prevalence of complete edentulism remains high in the elderly, and previous data have shown that poor denture hygiene is common among patients with edentulism. PURPOSE: The purpose of this randomized crossover trial was to evaluate the efficacy of denture cleansers in terms of biofilm removal, antimicrobial action, and the remission of denture stomatitis. MATERIAL AND METHODS: Fifty denture wearers with denture stomatitis were instructed to brush their dentures (brush and soap) and to soak them (20 minutes/14 days) in 4 solutions, as follows: C (control), 0.85% saline; SH1, 0.1% sodium hypochlorite; SH2, 0.2% sodium hypochlorite; and RC, 8% Ricinus communis. The biofilm in the intaglio surface of maxillary dentures was stained, photographed, and quantified by software (Image Tool). It was then collected (brushed with saline solution), and the obtained suspension was diluted (100 to 10-3) and seeded (50 µL) in CHROMagar for Candida spp. After incubation, colony-forming units per milliliter values were calculated. Denture stomatitis remission was classified according to the Newton classification. Data were analyzed by Friedman (α=.05) and Wilcoxon tests and corrected by the Bonferroni test (α=.005). RESULTS: SH1 (mean rank [MR]=1.98) and SH2 (MR=1.64) showed lower biofilm coverage than C (MR=3.73) that was similar to RC (MR=2.92). SH1 (MR=2.43) and SH2 (MR=2.10) showed antimicrobial action for Candida spp, and RC (MR=3.36) showed similar results to C (MR=3.51) and baseline (MR=3.50). Clinical signs of denture stomatitis were reduced by SH1 (MR=2.44), while SH2 (MR=2.56) and RC (MR=2.74) showed intermediate results. CONCLUSIONS: The two sodium hypochlorite solutions were the most effective means of biofilm control. All tested solutions were effective in reducing the signs of denture stomatitis.
Subject(s)
Biofilms/drug effects , Castor Oil/therapeutic use , Denture Cleansers/therapeutic use , Disinfectants/therapeutic use , Ricinus , Sodium Hypochlorite/therapeutic use , Aged , Aged, 80 and over , Cross-Over Studies , Dentures/microbiology , Female , Humans , Male , Middle Aged , Stomatitis, Denture/prevention & control , Treatment OutcomeABSTRACT
Alterations of the skin microvasculature are known to play an important role in the development and maintenance of psoriatic skin lesions. In this study, we investigated lesional skin in 11 psoriatic patients during a modified Goeckerman treatment using reflectance confocal microscopy (RCM) to study the relationship between clinical clearance and histological normalization of psoriatic skin and the significance of histological abnormalities on the course of disease. The treatment regimen resulted in a significant reduction of the Psoriasis Area and Severity Index (PASI) as well as capillary and papillary diameters (p < 0.0001). The capillary and papillary diameters were still enlarged when compared to those in normal skin (p < 0.001). Capillary and papillary diameters correlated with each other prior to and after treatment (correlation coefficient = 0.63 and 0.64, p = 0.01 and 0.002, respectively) but not with the PASI. Capillary and papillary diameters after treatment and percentage reduction of the PASI during treatment seemed to be better predictors for the clinical course of relapse than the PASI after treatment. These findings make the subclinical changes of psoriatic skin vessels and dermal papillae a legitimate target for treatment. Further investigations of a large group of patients are needed to evaluate the potential of RCM findings as successor of the PASI in the monitoring of psoriasis.
Subject(s)
Psoriasis/pathology , Psoriasis/therapy , Skin/pathology , Anthralin/therapeutic use , Capillaries/pathology , Capillaries/physiology , Castor Oil/therapeutic use , Coal Tar/therapeutic use , Female , Humans , Male , Microscopy, Confocal , Middle Aged , Pilot Projects , Psoriasis/physiopathology , Salicylic Acid/therapeutic use , Salts/therapeutic use , Severity of Illness Index , Skin/blood supply , Ultraviolet TherapyABSTRACT
This study evaluates and compares the effects of enamel prophylaxis using either oil-free pumice or oil-containing prophylaxis paste on the incidence of bracket failure in orthodontic patients. Forty-six orthodontic patients participated in this prospective clinical trial. A cross-mouth method was used in each patient, in which two diagonal quadrants (i.e. upper right and lower left or vice versa) were randomly assigned to the pumice group and the contralateral diagonal quadrants to the Prophy Paste group. A total of 836 teeth were bonded using Transbond XT (3M Unitek) and monitored for an average of 23 months for bond failure. Chi-square analysis was used to compare the number of bracket failures between the groups. Overall, 26 bond failures occurred by the end of the trial. Fifteen bracket failures were observed in the Prophy Paste group (3.6%) and 11 in the pumice group (2.6%). The failure rates were fairly evenly distributed between the upper and lower jaws. There were no statistically significant differences between the groups (P = 0.43). This study showed that enamel prophylaxis using either pumice or Prophy Paste before orthodontic bonding works equally well in a clinical setting.
Subject(s)
Dental Bonding , Dental Enamel/anatomy & histology , Dental Prophylaxis/methods , Orthodontic Brackets , Acid Etching, Dental/methods , Adolescent , Castor Oil/therapeutic use , Equipment Failure , Female , Follow-Up Studies , Glycerol/therapeutic use , Humans , Light-Curing of Dental Adhesives/methods , Male , Prospective Studies , Resin Cements/chemistry , Silicates/therapeutic use , Sodium Fluoride/therapeutic use , Toothpastes/therapeutic useABSTRACT
The corneal-protective effects of an artificial tear containing sodium hyaluronate (SH) and castor oil (CO) were evaluated on a porcine short-term dry eye model. Fresh porcine eyes with an intact cornea were treated with an artificial tear of saline, SH solution (0.1%, 0.5% or 1%), CO solution (0.5%, 1% or 5%) or a mixture solution containing 0.5% SH and 1% CO and then desiccated for 60, 90 or 180 min. To assess corneal damage, the eyes were stained with methylene blue (MB) or lissamine green (LG). The staining score of MB, absorbance of MB extracted from the cornea and staining density of LG increased significantly with increasing desiccation time in untreated and all artificial tear-treated eyes, although there were no significant differences in staining scores and absorbance of MB between eyes treated continuously with saline and 1% SH-treated ones at 60 and 90 min of desiccation or the mixture-treated eyes at 60 min of desiccation. No significant differences in the staining density of LG were also found between continuous saline-treated eyes and ones desiccated for 60 min and treated with 1% SH and the mixture. Mild cytoplasmic vacuolations were histopathologically observed in the basal and wing cells in eyes desiccated for 60 min and treated with 1% SH and the mixture. The mixture solution containing 0.5% SH and 1% CO has protective effects against corneal desiccation similar to those of 1% SH and would be helpful as an artificial tear.
Subject(s)
Castor Oil/pharmacology , Cornea/drug effects , Dry Eye Syndromes/drug therapy , Hyaluronic Acid/pharmacology , Lubricant Eye Drops/pharmacology , Animals , Castor Oil/administration & dosage , Castor Oil/therapeutic use , Histocytochemistry/veterinary , Hyaluronic Acid/administration & dosage , Hyaluronic Acid/therapeutic use , In Vitro Techniques/veterinary , Lubricant Eye Drops/administration & dosage , Lubricant Eye Drops/therapeutic use , Statistics, Nonparametric , SwineABSTRACT
BACKGROUND: Median sternotomy provides excellent access to all mediastinal structures in patients undergoing conventional cardiovascular surgery. Although this incision technique is associated with relatively lower complication rates, certain complications such as the sternal dehiscence may pose serious health consequences. In this regard, considerable effort has been paid to develop techniques aiming to improve sternal healing and to enhance postoperative recovery after conventional cardiac surgery. Among these, kryptonite bone cement, a biocompatible polymer with improved mechanical properties when combined with a standard wire cerclage, represents a promising novel approach that may help prevent sternal dehiscence. In this study, the effects of this particular type of bone cement on sternal healing, postoperative pain, and quality of life have been evaluated. METHODS: Kryptonite bone cement enhanced sternal closure was employed in a total of 100 patients undergoing conventional cardiac surgery between November 2009 and June 2012. Of these patients, 50 expressed their willingness to participate in this study. Each participant underwent a computerized tomography imaging for the radiological assessment of sternal healing. Pain and life quality of these patients have been evaluated by Wong-Baker faces pain scale and SF-36 health survey questionnaire, respectively. RESULTS: Mean duration of follow-up was 20.14 ± 7.36 months (range: 10-32). Mean age and body mass index were 71.32 ± 7.23 years (range: 55-85) and 28.34 ± 2.62 (21-34) kg/m2, respectively. Elderly patients (≥70), females and those with chronic obstructive pulmonary disease (COPD) comprised 64%, 26% and 40% of the study population, respectively. No patients had findings suggestive of dehiscence on CT images. No patients reported severe pain (i.e. all patients had a Wong-Baker faces pain scale score <4). Elderly (≥ 70 yr) subjects had better quality of life scores as compared to the remaining group of patients (< 70 yr) according to SF-36 Health Survey results. Vitality and emotional role scores were lower (63.5 ± 25.5, p = 0.018 and 41.7 ± 23.3, p = 0.001, respectively) in female patients. Patients with COPD had lower quality of life scores than those without COPD, particularly with respect to general health scores (73.3 ± 18.5; p = 0.012). CONCLUSIONS: Kryptonite bone cement, when combined with a standard wire cerclage, enhances mechanical strength, prevents sternal dehiscence, reduces postoperative pain and improves quality of life after conventional cardiac surgery. Long-term studies are warranted to better define the role of kryptonite bone cement in the prevention of sternal dehiscence.
Subject(s)
Cardiac Surgical Procedures , Castor Oil/therapeutic use , Pain, Postoperative/prevention & control , Polymers/therapeutic use , Quality of Life , Sternotomy/methods , Sternum/surgery , Wound Closure Techniques , Aged , Aged, 80 and over , Bone Wires , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pain Measurement , Surveys and Questionnaires , Treatment Outcome , Wound HealingABSTRACT
PURPOSE: To evaluate in vitro ability the of three different biomaterials - purified hydroxyapatite, demineralized bone matrix and castor oil-based polyurethane - as biocompatible 3D scaffolds for canine bone marrow mesenchymal stem cell (MSC) intending bone tissue engineering. METHODS: MSCs were isolated from canine bone marrow, characterized and cultivated for seven days with the biomaterials. Cell proliferation and adhesion to the biomaterial surface were evaluated by scanning electron microscopy while differentiation into osteogenic lineage was evaluated by Alizarin Red staining and Sp7/Osterix surface antibody marker. RESULTS: The biomaterials allowed cellular growth, attachment and proliferation. Osteogenic differentiation occurred in the presence of hydroxyapatite, and matrix deposition commenced in the presence of the castor oil-based polyurethane. CONCLUSION: All the tested biomaterials may be used as mesenchymal stem cell scaffolds in cell-based orthopedic reconstructive therapy.
Subject(s)
Bone Matrix , Bone Substitutes/therapeutic use , Castor Oil/therapeutic use , Durapatite/therapeutic use , Mesenchymal Stem Cells/drug effects , Polyurethanes/therapeutic use , Tissue Scaffolds , Animals , Bone Regeneration/drug effects , Cell Adhesion , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Dogs , Materials Testing , Mesenchymal Stem Cells/cytology , Microscopy, Electron, Scanning , Osteogenesis/drug effects , Surface Properties , Tissue EngineeringABSTRACT
PURPOSE: To evaluate in vitro ability the of three different biomaterials - purified hydroxyapatite, demineralized bone matrix and castor oil-based polyurethane - as biocompatible 3D scaffolds for canine bone marrow mesenchymal stem cell (MSC) intending bone tissue engineering. METHODS: MSCs were isolated from canine bone marrow, characterized and cultivated for seven days with the biomaterials. Cell proliferation and adhesion to the biomaterial surface were evaluated by scanning electron microscopy while differentiation into osteogenic lineage was evaluated by Alizarin Red staining and Sp7/Osterix surface antibody marker. RESULTS: The biomaterials allowed cellular growth, attachment and proliferation. Osteogenic differentiation occurred in the presence of hydroxyapatite, and matrix deposition commenced in the presence of the castor oil-based polyurethane. CONCLUSION: All the tested biomaterials may be used as mesenchymal stem cell scaffolds in cell-based orthopedic reconstructive therapy.
Subject(s)
Animals , Dogs , Bone Matrix , Bone Substitutes/therapeutic use , Castor Oil/therapeutic use , Durapatite/therapeutic use , Mesenchymal Stem Cells/drug effects , Polyurethanes/therapeutic use , Tissue Scaffolds , Bone Regeneration/drug effects , Cell Adhesion , Cells, Cultured , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Materials Testing , Microscopy, Electron, Scanning , Mesenchymal Stem Cells/cytology , Osteogenesis/drug effects , Surface Properties , Tissue EngineeringABSTRACT
Root perforations may lead to a loss of integrity in the root and periodontium, violations of the biologic periodontal distance, and injuries to periodontal tissue. This study sought to analyze the effect of root canal biomechanical preparation on the microhardness and the marginal sealing ability of different materials used to treat root perforations. Standard root perforations were performed in 96 bovine incisors. The teeth were divided into four groups (n = 24), based on the material used to treat those teeth: Mineral trioxide aggregate (MTA) (Group 1), MTA protected with cyanoacrylate (Group 2), MTA protected with glass ionomer (GI) cement (Group 3), and castor oil bean (COB) cement (Group 4). After root perforations were closed, the root canals were prepared biomechanically and teeth were sectioned longitudinally. Microleakage and microhardness of sealed perforations were assessed; microleakage data were submitted to analysis of variance (ANOVA) testing, while microhardness data were submitted to Dunnet and Tukey tests (p < 0.05). Group 4 reported the lowest amount of microleakage (0.65 mm), followed by Group 3 (1.02 mm), Group 1 (1.14 mm), and Group 2 (1.30 mm); however, no difference was detected among the groups. Groups 1-3 demonstrated significantly higher microhardness values compared to COB. It was concluded that the chemical and mechanical agents used during root canal preparation did not affect the sealing procedures. Administering surface protection to MTA did not improve microhardness or sealing.
Subject(s)
Dental Bonding , Dental Pulp Cavity/injuries , Root Canal Filling Materials/chemistry , Aluminum Compounds/chemistry , Aluminum Compounds/therapeutic use , Animals , Biomechanical Phenomena , Calcium Compounds/chemistry , Calcium Compounds/therapeutic use , Castor Oil/chemistry , Castor Oil/therapeutic use , Cattle , Cyanoacrylates/chemistry , Cyanoacrylates/therapeutic use , Dental Cements/chemistry , Dental Cements/therapeutic use , Dental Leakage/classification , Drug Combinations , Fluorescent Dyes , Glass Ionomer Cements/chemistry , Glass Ionomer Cements/therapeutic use , Hardness , Humidity , Materials Testing , Oxides/chemistry , Oxides/therapeutic use , Rhodamines , Root Canal Filling Materials/therapeutic use , Root Canal Preparation/methods , Silicates/chemistry , Silicates/therapeutic use , Surface Properties , Temperature , Time FactorsABSTRACT
OBJETIVO: Determinar se a reação tecidual do implante retroperitoneal do polímero de óleo de mamona (Pm) é significativa ou não por meio de análise histopatológica, tendo como controle o implante de titânio (Ti). MÉTODOS: Estudo experimental, intervencionista e randomizado com 32 cobaias. Os animais foram divididos em quatro grupos iguais e eutanasiados com 7, 20, 30 e 40 dias após o ato cirúrgico. Foram confeccionadas lâminas em hematoxilina-eosina e em tricrômio de Masson. Na comparação dos tipos de material em relação a variáveis quantitativas, foi considerado o teste não-paramétrico de Wilcoxon. Em relação a essas variáveis, os grupos definidos pelo dia do sacrifício foram comparados usando-se o teste não-paramétrico de Kruskal-Wallis. Os resultados obtidos no estudo da fibrose foram expressos por frequências e percentuais. Para a comparação entre os grupos definidos pelo dia do sacrifício, em relação a variáveis qualitativas dicotômicas da fibrose, foi considerado o teste exato de Fisher. Para avaliar a diferença entre os materiais titânio e polímero em cada grupo, ainda em se tratando da fibrose, foi considerado o teste binomial. Valores de P<0,05 indicaram significância estatística. RESULTADOS: A análise das variáveis quantitativas não demonstrou diferença nas reações teciduais entre os materiais (P>0,05). A análise da variável qualitativa também não demonstrou diferença entre as reações teciduais dos materiais (P>0,05). CONCLUSÃO: Não foi encontrada significância estatística entre a reação tecidual do Pm e do Ti.
OBJECTIVE: The aim of the present investigation is to determine if the tissue reaction to the Riccinus communis (mamona) polymer has significant statistical difference compared to the tissue reaction provoked by the titanium implant. METHODS: Thirty two Cavia porcellus were divided into four groups containing eight animals each one. We implanted the two types of materials in the retroperitoneal space of all the animals. They were sacrificed at 7, 20, 30 and 40 days after surgery and the samples were submitted to histological study. RESULTS: The quantitative analysis did not show difference between the tissue reaction of the two materials (P>0.05). The analysis of the qualitative variable also did not show difference between the tissue reaction of the materials (P>0.05). CONCLUSION: Macroscopic and microscopic results showed that the castor oil polymer implant has no significant statistical difference compared to the titanium implant tissue reaction.
Subject(s)
Animals , Guinea Pigs , Male , Biocompatible Materials/therapeutic use , Castor Oil/therapeutic use , Heart, Artificial , Polymers/therapeutic use , Ricinus , Titanium/therapeutic use , Fibrosis/pathology , Giant Cells , Histiocytes , Implants, Experimental , Lymphocytes , Materials Testing , Models, Animal , Neutrophils , Random Allocation , Reproducibility of Results , Treatment OutcomeABSTRACT
PURPOSE: To evaluate the biologic behavior of the castor polymer containing silica nanoparticles as a bone substitute in diafisary defect. METHODS: Twenty seven male rattus norvegicus albinus wistar lineage were submitted to bone defect filled with castor oil polymer. Three experimental groups had been formed with nine animals each: (1) castor oil polymer containing only calcium carbonate; (2) castor oil polymer with calcium carbonate and doped with 5 percent of silica nanoparticles; (3) castor polymer with calcium carbonate doped with 10 percent of silica nanoparticles; 3 animals of each group were submitted to euthanasia 15, 30 and 60 days after experimental procedure, and their femurs were removed to histological evaluation. RESULTS: there was bone growth in all the studied groups, with a greater tendency of growth in the group 1. After 30 days all the groups presented similar results. After 60 days a greater amount of fibroblasts, osteoblasts, osteocytes and osteoclasts in group 3 was observed, with integrated activity of 3 kinds of cells involved in the bone activation-reabsorption-formation. CONCLUSIONS: The castor polymer associated to the silica nanoparticles is biocompatible and allows osteoconduction. The presence of osteoprogenitors cells suggests silica osteoinduction capacity.
OBJETIVO: Avaliar o comportamento biológico do polímero de mamona contendo nanopartículas de sílica como substituto ósseo. MÉTODOS: Vinte e sete rattus norvergicus albinus, Wistar foram submetidos a defeito ósseo preenchido com polímero de mamona. Foram formados três grupos experimentais, com nove ratos cada: (1) Polímero com carbonato de cálcio; (2) Polímero com carbonato de cálcio dopado com 5 por cento de nanopartículas de sílica; (3) Polímero com carbonato de cálcio dopado com 10 por cento de nanopartículas de sílica; três animais de cada grupo foram submetidos à eutanásia 15, 30 e 60 dias após o procedimento experimental e os fêmures removidos e submetidos à avaliação histológica. RESULTADOS: Houve crescimento ósseo em todos os grupos estudados, com maior tendência de crescimento no grupo contendo polímero de mamona acrescido apenas por carbonato de cálcio. Aos 30 dias, todos os grupos apresentaram resultados semelhantes. Aos 60 dias, notou-se maior presença de fibroblastos, osteoblastos, osteócitos e osteoclastos no grupo 3, com persistência da atividade integrada dos três tipos de células envolvidas no processo de ativação-reabsorção-formação óssea. CONCLUSÕES: O polímero de mamona associado com nanopartículas de sílica é biocompatível e permite a osteocondução. A presença de células osteoprogenitoras nos implantes contendo 10 por cento de sílica indica sua capacidade osteoindutora.